Suppliers

Viral Safety for mAb: Prevent, Detect, Remove

Viral Safety for mAb: Prevent, Detect, Remove

Viral safety is a critical aspect of biopharmaceutical/biologics production and relies on the well-established principles of “prevent, detect and remove” to assure drug safety for patients. These principles are the foundation of every viral safety strategy and depend on the approaches outlined below:

Prevent:​ Careful selection and pretreatment of raw materials to prevent adventitious viruses from entering processes
Detect:​ Testing for the presence of viruses and other adventitious agents in cell banks, raw materials, and process intermediates
Remove:​ Implementation of technologies to remove or inactivate viruses and execute clearance studies to demonstrate process safety

There is no single viral safety solution that works for every process. Working with a partner with experience in all aspects of viral safety assurance can accelerate your drug development process and provide peace of mind.

Related resources

Rapid Biosafety Testing Enables the Future of Manufacturing

Rapid Biosafety Testing Enables the Future of Manufacturing

Content provided by Viral Safety for mAb: Prevent, Detect, Remove | 23-Nov-2020 | White Paper

This white paper explores the factors driving the evolution toward faster biosafety testing and describes rapid approaches for adventitious agent testing...

Blazar™ Platform: Rodent Virus Panel

Blazar™ Platform: Rodent Virus Panel

Content provided by Viral Safety for mAb: Prevent, Detect, Remove | 16-Nov-2020 | White Paper

We have a long history of developing innovative molecular technologies for cell line characterization and lot release testing for the biopharmaceutical...